Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Sarcoma 1

Conditions

Sarcoma 3Soft Tissue Neoplasms 1Rhabdomyosarcoma 1Osteosarcoma 1Oligodendroglioma 1Neoplasms 1Lymphoma 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 45Radiotherapy 20Filgrastim 17Carmustine 15Carboplatin 15Irinotecan 13Bevacizumab 13Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 11Peripheral Blood Stem Cell Transplantation 9Erlotinib Hydrochloride 9sargramostim 8O(6)-benzylguanine 8Radiation 7Topotecan 6Thiotepa 6Radiotherapy, Intensity-Modulated 6Procarbazine 6Etoposide 6Drug Therapy 6Cyclophosphamide 6Chemotherapy, Adjuvant 6aldesleukin 5Vorinostat 5Sirolimus 5Imatinib Mesylate 5Granulocyte Colony-Stimulating Factor 5Busulfan 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5temsirolimus 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × Magnetic Resonance Imaging × Sarcoma × Clear all
NCT00433472 2015-07-29

MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Withdrawn
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡